Inhibition of TGF-β-induced apoptosis by ethinyl estradiol in cultured, precision cut rat liver slices and hepatocytes

Carcinogenesis

Volumn 21, Issue 6, 2000, Pages 1205-1211

  Chen, Jinqiang ^a   Gokhale, Mamata ^a,b   Schofield, Brian ^a   Odwin, Shelly ^a   Yager, James D ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; DNA FRAGMENT; ETHINYLESTRADIOL; PEROXISOME PROLIFERATOR; PHENOBARBITAL; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GEL ELECTROPHORESIS; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; LIVER CARCINOGENESIS; LIVER CELL CULTURE; LIVER SLICE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034131116     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.6.1205     Document Type: Article

References (50)

1. Palmer, J.R., Rosenberg, L., Kaufman, D.W., Warshauer, M.E., Stolley, P. and Shapiro, S. (1989) Oral contraceptive use and liver cancer. Am. J. Epidemiol., 130, 878-882.
2. Yager, J.D. and Liehr, J.G. (1996) Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 36, 203-232.
3. Yager, J.D., Roebuck, B.D., Puluszcyk, T.L. and Memoli, V.A. (1986) Effects of ethinyl estradiol and tamoxifen in liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats. Carcinogenesis, 7, 2007-2014.
4. Mayol, X., Perez-Tomas, P., Cullere, X., Romero, A., Estadella, M.D. and Dominggo, J. (1991) Cell proliferation and tumor promotion by ethinyl estradiol in rat hepatocarcinogenesis. Carcinogenesis, 12, 1133-1136.
5. Mayol, X., Neal, G.E., Davies, R., Romero, A. and Domingo, J. (1992) Ethinyl estradiol-induced cell proliferation in rat liver. Involvement of specific populations of hepatocytes. Carcinogenesis, 13, 2381-2388.
6. Yager, J.D., Zurlo, J., Sewall, H.C., Lucier, G.W. and He, H. (1994) Growth stimulation followed by growth inhibition in livers of female rats treated with ethinyl estradiol. Carcinogenesis, 15, 2117-2123.
7. Barbason, H., Rassenfose, C. and Betz, E.H. (1983) Promotion mechanism of phenobarbital and partial hepatectomy in DENA hepatocarcinogenesis cell kinetic effect. Br. J. Cancer, 47, 517-525.
8. Abanobi, S.E., Lombardi, B. and Shinozuka, H. (1982) Stimulation of DNA synthesis and cell proliferation in the liver of rats fed a choline-devoid diet and their suppression by phenobarbital. Cancer Res., 42, 412-415.
9. Jirtle, R.L. and Meyer, S.A. (1991) Liver tumor promotion, effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor-beta expression. Dig. Dis. Sci., 36, 659-668.
10. Tanaka, K., Smith, P.E., Stromberg, P.C., Eydelloth, R.S., Herold, E.G., Grossman, S.J., Frank, J.D., Hertzog, P.R., Soper, K.A. and Keenan, K.P. (1992) Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate. Toxicol. Appl. Pharmacol., 116, 71-77.
11. Styles, J.A., Kelly, M.D., Elcombe, C.R., Bybee, A. and Pritchard, N.R. (1991) Recovery of hyperplastic reponsiveness in rat liver after dosing with the peroxisome proliferate methylclofenapate. Carcinogenesis, 12, 2127-2133.
12. Jirtle, R.L., Hankins, G.R., Reisenbichler, H. and Boyer, I.J. (1994) Regulation of mannose 6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbital. Carcinogenesis, 15, 1473-1478.
13. Chen, J.Q., Schwartz, D.A., Young, T.A., Norris, J.S. and Yager, J.D. (1996) Identification of genes whose expression is altered during mitosuppression in livers of ethinyl estradiol-treated female rats. Carcinogenesis, 17, 2783-2786.
14. Rumsby, P.C., Davies, M.J., Price, R.J. and Lake, B.G. (1994) Effect of some peroxisomal proliferators on transforming growth factor-β1 gene expression and insulin-like growth factor II/mannose-6-phosphate receptor gene expression in rat liver. Carcinogenesis, 15, 419-421.
15. Schulte-Hermann, R., Bursch, W., Grasl-Kraupp, B., Marian, B., Torok, L., Kahl-Rainer, P. and Ellinger, A. (1997) Concepts of cell death and application to carcinogenesis. Toxicol. Pathol., 25, 89-93.
16. Schulte-Hermann, R., Bursch, W., Kraupp-Grasl, B., Oberhammer, F., Wagner, A. and Jirtle, R. (1993) Cell proliferation and apoptosis in normal liver and preneoplastic foci. Environ. Health Perspect., 101 (suppl. 5), 87-90.
17. Bursch, W., Lauer, B., Timmermann-Trosiener, I., Barthel, G., Schuppler, J. and Schulte-Hermann, R. (1984) Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis, 5, 453-458.
18. Schulte-Hermann, R., Timmermann-Trosiener, I., Barthel, G. and Bursch, W. (1990) DNA synthesis, apoptosis and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res., 50, 5127-5135.
19. Bursch, W., Oberhammer, F., Jirtle, R.L., Askari, M., Sedivy, R., GraslKraupp, B., Purchio, A.F. and Schulte-Hermann, R. (1993) Transforming growth factor-β1 as a signal for induction of cell death by apoptosis. Br. J. Cancer, 67, 531-536.
20. Oberhammer, F.A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A.F., Bursch, W. and Schulte-Hermann, R. (1992) Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc. Natl Acad. Sci. USA, 89, 5408-5412.
21. Oberhammer, F., Bursch, W., Parzefall, W., Breit, P., Erber, E., Stadler, M. and Schulte-Hermann, R. (1991) Effect of transforming growth factor β on cell death of cultured rat hepatocytes. Cancer Res., 51, 2478-2485.
22. Oberhammer, F., Fritsch, G., Pavelka, M., Froschl, G., Tiefenbacher, R., Purchio, T. and Schulte-Hermann, R. (1992) Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor-β1 occurs without activation of an endonuclease. Toxicol. Lett., 64, 701-704.
23. Bayly, A.C., Roberts, R.A. and Dive, C. (1994) Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisomal proliferator nafenopin. J. Cell Biol., 125, 197-203.
24. Christensen, J.G., Gonzales, A.J., Cattley, R.C. and Goldsworthy, T.L. (1998) Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens. Cell Growth Differ., 9, 815-825.
25. Perrone, C.E., Shao, L. and Williams, G.M. (1998) Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-coA oxidase, DNA synthesis and apoptosis in cultured human and rat hepatocytes. Toxicol. Appl. Pharmacol., 150, 277-286.
26. Roberts, R.A., James, N.H., Woodyatt, N.J., Macdonald, N. and Tugwood, J.D. (1998) Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPARα). Carcinogenesis, 19, 43-48.
27. Zurlo, J. and Arterburn, L.M. (1996) Characterization of a primary culture system for toxicological studies. In Vitro Cell. Dev. Biol. Animal. 32, 211-220.
28. Gokhale, M.S., Bunton, T.E., Zurlo, J. and Yager, J.D. (1997) Cytochrome P450 isoenzyme activities in cultured rat and mouse liver slices. Xenobiotica, 27, 341-355.
29. Gavrieli, Y., Sherman, Y. and Ben-Sasson, S.A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119, 493-501.
30. Ha, H.C., Woster, P.M., Yager, J.D. and Casero, R.A., Jr. (1997) The role of polyamine catabolism in polyamine analogue-induced programmed cell death. Proc. Natl Acad. Sci. USA, 94, 11557-11562.
31. Yang, J., Liu, X., Bhalla, K., Kim, C.N., Ibrado, A.M., Cai, J., Peng, T.-I., Jones, D.P. and Wang, X. (1997) Prevention of apoptosis by Bcl2: release of cytochrome c from mitochondria blocked. Science, 275, 1129-1132.
32. Stahelin, B.J., Marti, U., Solioz, M., Zimmermann, H. and Reichen, J. (1998) False positive staining in the TUNEL assay to detect apoptosis in liver and intestine is caused by endogenous nucleases and inhibited by diethyl pyrocarbonate. J. Clin. Pathol. Mol. Pathol., 51, 204-208.
33. Arterbum, L.M., Zurlo, J., Yager, J.D., Overton, R.M. and Heifetz, A.H. (1995) A morphological study of differentiated hepatocytes in vitro. Hepatology, 21, 175-187.
34. Ogawa, T., Higashi, S., Kawarada, Y. and Muzumoto, R. (1995) Role of reactive oxygen in synthetic estrogen induction of hepatocellular carcinoma in rats and preventive effect of vitamins. Carcinogenesis, 16, 831-836.
35. Dennis, P.A. and Rifkin, D.B. (1991) Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin like growth factor type II receptor. Proc. Natl Acad. Sci. USA, 88, 580-584.
36. Chen, J., Gokhale, M., Li, Y., Trush, M.A. and Yager, J.D. (1998) Enhanced levels of several mitochondrial mRNA transcripts and mitochondrial superoxide production during ethinyl estradiol-induced hepatocarcino-genesis and after estrogen treatment of HepG2 cells. Carcinogenesis, 19, 2187-2193.
37. Sheikh, A., Yusuf, A., Laconi, E., Rao, P.M., Rajalakshmi, S. and Sarma, D.S.R. (1993) Effect of orotic acid on in vivo DNA synthesis in hepatocytes of normal rat liver and in hepatic foci/nodules. Carcinogenesis, 14, 907-912.
38. Cattley, R.C. and Glover, S.E. (1993) Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to carcinogenesis and nuclear localization. Carcinogenesis, 14, 2495-2499.
39. Takagi, A., Sai, K., Umemura, T., Hasegawa, R. and Kurokawa, Y. (1990) Relationship between hepatic peroxisome proliferation and 8-hydroxyguanosine formation in liver DNA of rats following long-term exposure to three peroxisome proliferators; di(2-ethylhexyl)phthlate, aluminium clofibrate and simfibrate. Cancer Lett., 53, 33-38.
40. Kasai, H., Okada, Y., Nishimura, S., Rao, M.S. and Reddy, J.K. (1989) Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to peroxisome proliferator. Cancer Res., 49, 2603-2605.
41. Li, Y., Leung, L.K., Spear, B.T. and Glauert, H.P. (1996) Activation of hepatic NF-κB by phenobarbital in rats. Biochem. Biophys. Res. Commun., 229, 982-989.
42. Li, Y., Leung, L.K., Glauert, H.P. and Spear, B.T. (1996) Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-κB activity. Carcinogenesis, 17, 2305-2309.
43. Li, N. and Karin, M. (1999) Is NF-κB the sensor of oxidative stress? FASEB J., 13, 1137-1143.
44. Strange, J. and Roberts, R.A. (1996) Reduced expression of mature TGFβ1 correlates with the suppression of rat hepatocyte apoptosis by the peroxisome proliferator, nafenopin. Mutat. Res., 372, 107-113.
45. Garcia-Segura, L.M., Cardona-Gomez, P., Naftolin, F. and Chowen, J.A. (1998) Estradiol upregulates Bcl-2 expression in adult brain neurons. Neuroreport, 9, 593-597.
46. Mattson, M.P., Robinson, N. and Guo, Q. (1997) Estrogens stabilize mitochondrial function and protects neural cells against the pro-apoptotic action of mutant presenilin-1. Neuroreport, 17, 3817-3821.
47. Wang, T.T.Y. and Phang, J.M. (1995) Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res., 55, 2487-2489.
48. Huang, Y.L. and Chou, C.K. (1998) Bcl-2 blocks apoptotic signal of transforming growth factor-beta in human heputoma cells. J. Biomed. Sci., 5, 185-191.
49. Christensen, J.G., Romach, E.H., Healy, L.N., Gonzales, A.J., Anderson, S.P. Malarkey, D.E., Corton, J.C., Fox, T.R., Cattley, R.C. and Goldsworthy, T.L. (1999) Altered Bcl-2 family expression during non-genotoxic hepatocarcinogenesis in mice. Carcinogenesis, 20, 1583-1590.
50. Brown, T.L., Patil, S., Basnett, R.K. and Howe, P.H. (1998) Caspase inhibitor BD-fmk distinguishes transforming growth factor β-induced apoptosis from growth inhibition. Cell Growth Differ., 9, 869-875.